Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 360 results:
Συντάκτης [ Τίτλος(Desc)] Τύπος Έτος
Φίλτρα: Συντάκτης is Polyzos, Stergios A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
E
Kountouras, J., Zavos C., Polyzos S. A., Katsinelos P., & Stergiopoulos C. (2014).  Eradication of Helicobacter pylori infection might have a positive impact on subpopulations with endoscopic gastro-oesophageal reflux disease.. Eur J Gastroenterol Hepatol. 26(1), 123.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'.. Carcinogenesis.
Franceschi, F., Gasbarrini A., Polyzos S. A., & Kountouras J. (2015).  Extragastric Diseases and Helicobacter pylori.. Helicobacter. 20 Suppl 1, 40-6.
F
Venetsanaki, V., Karabouta Z., & Polyzos S. A. (2019).  Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitis.. Eur J Pharmacol. 863, 172661.
Polyzos, S. A., Perakakis N., & Mantzoros C. S. (2019).  Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement.. Metabolism. 96, 66-82.
Dalamaga, M., Polyzos S. A., Karmaniolas K., Chamberland J., Lekka A., Triantafilli M., et al. (2016).  Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study.. Leuk Lymphoma. 57(3), 577-84.
Raptis, D. D., Mantzoros C. S., & Polyzos S. A. (2023).  Fibroblast Growth Factor-21 as a Potential Therapeutic Target of Nonalcoholic Fatty Liver Disease.. Ther Clin Risk Manag. 19, 77-96.
Seo, Y-G., Polyzos S. A., Park K-H., & Mantzoros C. S. (2023).  Fibrosis-4 index predicts long-term all-cause, cardiovascular and liver-related mortality in the adult Korean population.. Clin Gastroenterol Hepatol.
Anastasilakis, A. D., Makras P., Polyzos S. A., & Papapoulos S. E. (2023).  The Five-Year Effect of a Single Zoledronate Infusion on Bone Mineral Density Following Denosumab Discontinuation in Women with Postmenopausal Osteoporosis.. Calcif Tissue Int.
Anastasilakis, A. D., Koulaxis D., Upadhyay J., Pagkalidou E., Kefala N., Perakakis N., et al. (2019).  Free IGF-1, Intact IGFBP-4, and PicoPAPP-A are Altered in Acute Myocardial Infarction Compared to Stable Coronary Artery Disease and Healthy Controls.. Horm Metab Res. 51(2), 112-119.
G
Kountouras, J., Doulberis M., Papaefthimiou A., & Polyzos S. A. (2019).  Gastroesophageal reflux disease, irritable bowel syndrome and functional dyspepsia as overlapping conditions: focus on effect of trimebutine.. Ann Gastroenterol. 32(3), 318.
Kountouras, J., Kazakos E., Polyzos S. A., Chatzopoulos D., Tzitiridou-Chatzopoulou M., Doulberis M., et al. (2022).  GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection.. Helicobacter. 27(3), e12884.
Kountouras, J., Zavos C., Polyzos S. A., & Deretzi G. (2015).  The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systems.. Ann Gastroenterol. 28(4), 506.
H
Kountouras, J., Kapetanakis N., Zavos C., Polyzos S. A., Vardaka E., Katsinelos P., et al. (2014).  Helicobacter pylori and colorectal cancer risk--letter.. Cancer Epidemiol Biomarkers Prev. 23(2), 365.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2011).  Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact.. Saudi J Gastroenterol. 17(6), 425-6.
Kountouras, J., Polyzos S. A., & Deretzi G. (2015).  Helicobacter pylori Associated With Obstructive Sleep Apnea Might Contribute to Sleep, Cognition, and Driving Performance Disturbances in Patients With Cirrhosis.. Clin Gastroenterol Hepatol. 13(8), 1547.
Kountouras, J., Polyzos S. A., Katsinelos P., Zeglinas C., Artemaki F., Tzivras D., et al. (2017).  Helicobacter pylori eradication to prevent cardio-cerebrovascular disease: Are current data useful for clinical practice?. Int J Cardiol. 233, 92.
Kountouras, J., Zavos C., Deretzi G., Vardaka E., Boziki M., Gavalas E., et al. (2013).  Helicobacter pylori induced cognitive dysfunction might be associated with falls and fractures in cirrhosis.. Hepatology. 57(3), 1284.
Kapetanakis, N., Kountouras J., Zavos C., Polyzos S. A., Kouklakis G., Venizelos I., et al. (2012).  Helicobacter pylori infection and colorectal carcinoma: pathologic aspects.. J Gastrointest Oncol. 3(4), 377-9.
Polyzos, S. A., Papaefthymiou A., Doulberis M., Mavridoglou G., & Kountouras J. (2021).  Helicobacter pylori infection and diabetes mellitus.. Diabetes Metab Syndr. 15(3), 845-846.
Kountouras, J., Zavos C., Polyzos S. A., & Katsinelos P. (2015).  Helicobacter pylori infection and gastroesophageal reflux disease - Barrett's esophagus sequence "dilemma". Ann Gastroenterol. 28(1), 153.
Kountouras, J., Doulberis M., Polyzos S. A., Zeglinas C., Vardaka E., Kountouras C., et al. (2018).  Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.. Am J Gastroenterol. 113(11), 1723-1724.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Elisabeth V., et al. (2019).  Helicobacter pylori infection and gastrointestinal tract cancer biology: considering a double-edged sword reflection.. Cell Mol Life Sci. 76(13), 2487-2488.
Polyzos, S. A., Kountouras J., Zavos C., & Deretzi G. (2013).  Helicobacter pylori Infection and insulin resistance.. Helicobacter. 18(2), 165-6.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Helicobacter pylori infection and nonalcoholic fatty liver disease: Are the four meta-analyses favoring an intriguing association pointing to the right direction?. Metabolism. 96, iii-v.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές